5.720USD+5.34%Mkt Cap: 107.34M $P/E: 15.891d ago
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Mi…
Industry Peers
Health Information Servicesvs Health Information Services
P/E
Cheaper
P/B
Cheaper
1M Perf
Lower
$28.83BUSDP/E 31.5
$13.69BUSDP/E 90.6
$10.40BUSD
$7.57BUSDP/E 33.8
$6.42BUSD
$4.87BUSD
$3.94BUSDP/E 30.6
$3.24BUSDP/E 151.4
$2.53BUSD
$1.89BUSDP/E 94.4
$1.53BUSD
$1.30BUSD
$1.21BUSD
$1.02BUSD
$975.39MUSDP/E 48.0
$871.07MUSDP/E Infinity
$796.11MUSDP/E 40.7
$713.43MUSDP/E 33.6
$635.66MUSDP/E 64.3
$609.65MUSD
$563.71MUSDP/E 13.3
$581.50MUSD
$501.65MUSDP/E 28.1
$516.62MUSD
$462.84MUSDP/E 26.3
$486.12MUSDP/E 55.3
$476.60MUSD
$393.13MUSDP/E 90.4
$370.16MUSD
$282.18MUSD
$227.30MUSDP/E 13.9
$213.88MUSDP/E 17.4
$199.74MUSD
$154.92MUSDP/E 30.8
$145.80MUSDP/E 39.3
$152.38MUSD
$147.05MUSD
$134.30MUSDP/E Infinity
$119.30MUSDP/E 26.6
$90.09MUSDP/E 16.3
$87.68MUSD
$63.42MUSDP/E 11.0
$62.20MUSD
$61.11MUSDP/E 22.1
$48.56MUSDP/E 46.3
$47.87MUSDP/E 57.6
$48.26MUSD
$41.23MUSD
$41.63MUSD
$23.33MUSDP/E 55.8
$23.82MUSDP/E 23.0
$21.92MUSD
$19.31MUSD
$13.45MUSD
$13.16MUSD
$10.93MUSD
$9.67MUSDP/E 14.9
$9.47MUSD
$7.09MUSD
$6.52MUSD
$5.18MUSD
$5.62MUSD
$3.80MUSDP/E Infinity
$3.67MUSDP/E 0.0
$3.46MUSD
$3.38MUSD
$2.99MUSD
$1.44MUSDP/E Infinity
$512.9KUSDP/E 0.0
$373.4KUSD
$165.6KUSD
CRY
GraniteShares YieldBOOST CRCL ETF—
EYES
Corgi Data & Surveillance ETF—P/E 30.5
—
—
—
Indicators:|
Key Statistics
Company
Market Cap107.34M $
Enterprise Value110.88M $
Revenue (TTM)107.34M $
Gross Profit73.59M $
Net Income (TTM)5.13M $
Revenue/Share5.763 USD
Last Price5.720 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees132
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)15.89
P/E (Forward)5.24
PEG1.61
EV/EBITDA5.88
EV/Revenue1.03
P/S1.00
P/B0.84
EPS (TTM)0.36
EPS (Forward)1.09
52W Range
4.5407% of range22.25
52W High22.25 USD
52W Low4.540 USD
Profitability
Gross Margin67.25%
Oper. Margin2.00%
EBITDA Margin17.57%
Profit Margin4.69%
ROE4.00%
ROA2.90%
Growth
Revenue Growth-9.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF18.71M $
CapEx (TTM)—
FCF Margin10.57%
FCF Yield10.57%
Net Debt3.55M $
Net Debt/EBITDA0.19
Balance Sheet
Debt/Equity0.20
Current Ratio5.37
Quick Ratio5.07
Book Value/Sh6.839 USD
Cash/Share1.075 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMay 14, 2018
Splits
Last Split1:3
Split DateMay 14, 2018
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)12.40 USD
Upside (mean)+116.8%
Target Range9.000 USD – 18.00 USD
$9.000+116.8% to mean$18.00
# Analysts5
Ownership
Shares Out.18.77M
Float14.43M
Insiders12.88%
Institutions77.95%
Short Interest
Short Ratio5.0d
Short % Float10.34%
Short % Out.9.87%
Shares Short1.85M
Short (prev mo.)2.01M
Technical
SMA 505.606 (+2.0%)
SMA 20011.12 (-48.6%)
Beta1.10
S&P 52W Chg20.05%
Avg Vol (30d)407.98K
Avg Vol (10d)600.02K
Technical Indicators
RSI (14)59.9
MACD-0.0708
MACD Signal-0.1671
MACD Hist.+0.0963
BB Upper5.671 USD
BB Middle5.115 USD
BB Lower4.559 USD
BB Width21.74%
ATR (14)0.3515 USD
Vol Ratio (20d)1.21x